Our community thanks health professionals
At the GI Cancer Institute we have received an outpouring of messages of support for the health professionals... Read More
Our Future Trials
The GI Cancer Institute has four trials in development, unlocking new treatments for people with GI cancer. RoLaCaRT-1 Using a... Read More
The future of the GI Cancer Institute
A message from Dr Lorraine Chantrill, Chair of the GI Cancer Institute. Personally, I have a very strong family... Read More
Final patient joins the MODULATE clinical trial
The final patient participating in the MODULATE clinical trial has now joined, meaning that... Read More
COVID-19 April update
As the COVID-19 pandemic continues to evolve, we are also continuing to evolve the way we work –... Read More
Ruth Henwood creates a legacy to give hope to the future
Ruth’s Bequest is in memory of her late husband, Lance, who passed away from oesophageal cancer in 2013. Lance’s... Read More
Welcoming Erin Burgess as Communications Manager
Erin recently joined the AGITG and GI Cancer Institute as Communications Manager. How did you come to work in... Read More
Endorsed Studies: Spotlight on NEO-CREATE
The pilot study NEO-CREATE, led by study chair Dr Amitesh Roy, aims to assess the safety of adding... Read More
April 2020: AGITG Trial Updates
DYNAMIC-Pancreas DYNAMIC-Pancreas is one of three AGITG trials investigating ctDNA analysis, an emerging area in GI oncology that shows... Read More
Oesophageal cancer: Symptoms and Risk Factors
Oesophageal cancer is not as well known as some other forms of cancer, but 1,351 Australians lose their... Read More